APA (7th ed.) Citation

Loi, S., Michiels, S., Adams, S., Loibl, S., Budczies, J., Denkert, C., & Salgado, R. (2021). The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: Clinical utility in an era of checkpoint inhibition. Annals of oncology, 32(10), . https://doi.org/10.1016/j.annonc.2021.07.007

Chicago Style (17th ed.) Citation

Loi, S., S. Michiels, S. Adams, Sibylle Loibl, Jan Budczies, C. Denkert, and R. Salgado. "The Journey of Tumor-infiltrating Lymphocytes as a Biomarker in Breast Cancer: Clinical Utility in an Era of Checkpoint Inhibition." Annals of Oncology 32, no. 10 (2021). https://doi.org/10.1016/j.annonc.2021.07.007.

MLA (9th ed.) Citation

Loi, S., et al. "The Journey of Tumor-infiltrating Lymphocytes as a Biomarker in Breast Cancer: Clinical Utility in an Era of Checkpoint Inhibition." Annals of Oncology, vol. 32, no. 10, 2021, https://doi.org/10.1016/j.annonc.2021.07.007.